The University of Edinburgh,
School of Informatics
For several years COVVI has worked collaboratively with Dr Kia Nazarpour and the University of Edinburgh School of Informatics to further research and test the Nexus Hand in a clinical environment and collect vital diagnostics information that has aided the development of the prosthetic.
This is his experience with the Nexus Hand.
My name is Kia Nazarpour and I’m an engineer and an academic who has been working on advanced methods to control bionics hands for the past 20 years. I have also worked in the prosthetics industry and have the experience of taking ideas from the R&D department all the way to the final release product.
I have been working with COVVI for the last four years, seeing the evolution of the Nexus Hand to what it is today. In this time, I’ve seen it evolve with not only a sleek aesthetic, but a radically novel mechanical and electronic design with the genuine potential to meet user needs in terms of function.
I am privileged to have been using the Nexus Hand for research at my laboratory in Edinburgh. We have been working on the dextrous control of the hand, moving beyond grasp decoding with the so-called ‘pattern recognition’.
The unique design of the Nexus Hand allows us to monitor where exactly digits are in their movement range and adjust their positions according to the user’s intent. This coupled with the new design of the electrode array facilitates the development of prosthetic solutions that users would find fit for purpose.
In my opinion, COVVI has already disrupted the upper-limb prosthetic market and created a new translation pathway for cutting-edge science and engineering innovation.
Kia Nazarpour PhD SMIEEE FHEA
Reader in Biomedical AI
EPSRC Research Fellow – Healthcare Technologies
Edinburgh Neuroprosthetics Laboratory
School of Informatics, The University of Edinburgh
“Your aim to bring the concept of Internet of Things to the Nexus Hand will allow both us and the clinicians to closely monitor their devices, fixing the issue where all parties feel disconnected from one another after the patient leaves the clinic. This has the potential to not only reduce the cost of prosthetic services for the NHS by encouraging compliance, but also to increase the quality of life of prosthesis users.
We are very happy to be seriously involved in this challenge and are very excited to expand our relationship with you at The University of Edinburgh. We are in no doubt that such interactions are beneficial for the company, academic research as a whole and, of course, for our clinicians and users.”
Simon Pollard, Group CEO